{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:15:15Z","timestamp":1792696515359,"version":"4.5.0"},"reference-count":62,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22007062"],"award-info":[{"award-number":["22007062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005146","name":"Basic Research Programs of Sichuan Province","doi-asserted-by":"publisher","award":["202303021221128"],"award-info":[{"award-number":["202303021221128"]}],"id":[{"id":"10.13039\/501100005146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017692","name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.csbj.2025.12.026","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T23:51:22Z","timestamp":1767052282000},"page":"363-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bicuculline from\n                    <i>Forsythia suspensa<\/i>\n                    attenuates liver fibrosis via TLR4\/MD2 inhibition and suppression of MyD88\/NF-\u03baB signaling"],"prefix":"10.34133","volume":"31","author":[{"given":"Xiaozheng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine; Shanxi Key Laboratory of Birth Defect and Cell Regeneration; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guicai","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine; Shanxi Key Laboratory of Birth Defect and Cell Regeneration; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sili","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine; Shanxi Key Laboratory of Birth Defect and Cell Regeneration; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine; Shanxi Key Laboratory of Birth Defect and Cell Regeneration; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine; Shanxi Key Laboratory of Birth Defect and Cell Regeneration; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine; Shanxi Key Laboratory of Birth Defect and Cell Regeneration; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.97"},{"key":"e_1_3_6_3_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153609","article-title":"Schisantherin A ameliorates liver fibrosis through TGF-beta1mediated activation of TAK1\/MAPK and NF-kappaB pathways in vitro and in vivo","volume":"88","author":"Wang H.","year":"2021","unstructured":"Wang H., Che J., Cui K. et al: Schisantherin A ameliorates liver fibrosis through TGF-beta1mediated activation of TAK1\/MAPK and NF-kappaB pathways in vitro and in vivo. Phytomedicine 2021; 88: 153609.","journal-title":"Phytomedicine"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24282"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88881"},{"key":"e_1_3_6_6_2","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman S.L.","year":"2000","unstructured":"Friedman S.L.: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247.","journal-title":"J Biol Chem"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50182"},{"key":"e_1_3_6_8_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2004.10.020","article-title":"LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors","volume":"325","author":"Muhlbauer M.","year":"2004","unstructured":"Muhlbauer M., Weiss T.S., Thasler W.E. et al: LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors. Biochem Biophys Res Commun 2004; 325: 191.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20194"},{"key":"e_1_3_6_10_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lfs.2017.11.047","article-title":"Lycium barbarum polysaccharides improve CCl(4)-induced liver fibrosis, inflammatory response and TLRs\/NF-kB signaling pathway expression in wistar rats","volume":"192","author":"Gan F.","year":"2018","unstructured":"Gan F., Liu Q., Liu Y. et al: Lycium barbarum polysaccharides improve CCl(4)-induced liver fibrosis, inflammatory response and TLRs\/NF-kB signaling pathway expression in wistar rats. Life Sci 2018; 192: 205.","journal-title":"Life Sci"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07830"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1589"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1039\/c3cs60039d"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm401006s"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00631"},{"key":"e_1_3_6_16_2","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23648","article-title":"Tanshinone IIA regulates CCl(4) induced liver fibrosis in C57BL\/6J mice via the PI3K\/Akt and Nrf2\/HO-1 signaling pathways","volume":"38","author":"Li Q.","year":"2024","unstructured":"Li Q., Huang D., Liao W. et al: Tanshinone IIA regulates CCl(4) induced liver fibrosis in C57BL\/6J mice via the PI3K\/Akt and Nrf2\/HO-1 signaling pathways. J Biochem Mol Toxicol 2024; 38: e23648.","journal-title":"J Biochem Mol Toxicol"},{"key":"e_1_3_6_17_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154587","article-title":"Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-gamma\/STAT1\/Smad7 pathway","volume":"112","author":"Guo M.","year":"2023","unstructured":"Guo M., Wang Z., Dai J. et al: Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-gamma\/STAT1\/Smad7 pathway. Phytomedicine 2023; 112: 154587.","journal-title":"Phytomedicine"},{"key":"e_1_3_6_18_2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","article-title":"Silymarin as supportive treatment in liver diseases: a narrative review","volume":"37","author":"Gillessen A.","year":"2020","unstructured":"Gillessen A. and Schmidt H.H.: Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther 2020; 37: 1279.","journal-title":"Adv Ther"},{"key":"e_1_3_6_19_2","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s43440-021-00227-1","article-title":"Pharmacological properties of baicalin on liver diseases: a narrative review","volume":"73","author":"Yang J.Y.","year":"2021","unstructured":"Yang J.Y., Li M., Zhang C.L. et al: Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacol Rep 2021; 73: 1230.","journal-title":"Pharmacol Rep"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111598","article-title":"Wuling capsule modulates macrophage polarization by inhibiting the TLR4-NF-kappaB signaling pathway to relieve liver fibrosis","volume":"129","author":"Ren S.","year":"2024","unstructured":"Ren S., Zhou R., Tang Z. et al: Wuling capsule modulates macrophage polarization by inhibiting the TLR4-NF-kappaB signaling pathway to relieve liver fibrosis. Int Immunopharmacol 2024; 129: 111598.","journal-title":"Int Immunopharmacol"},{"key":"e_1_3_6_21_2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jhep.2022.07.018","article-title":"Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B","volume":"77","author":"Ji D.","year":"2022","unstructured":"Ji D., Chen Y., Bi J. et al: Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B. J Hepatol 2022; 77: 1515.","journal-title":"J Hepatol"},{"key":"e_1_3_6_22_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11655-012-1030-1","article-title":"Fuzheng huayu capsule in the treatment of liver fibrosis: clinical evidence and mechanism of action","volume":"18","author":"Liu P.","year":"2012","unstructured":"Liu P.: Fuzheng huayu capsule in the treatment of liver fibrosis: clinical evidence and mechanism of action. Chin J Integr Med 2012; 18: 398.","journal-title":"Chin J Integr Med"},{"key":"e_1_3_6_23_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru J.","year":"2014","unstructured":"Ru J., Li P., Wang J. et al: TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Chemin 2014; 6: 13.","journal-title":"J Chemin"},{"key":"e_1_3_6_24_2","first-page":"382","article-title":"Progress in computational methods for the prediction of ADMET properties","volume":"5","author":"DE Clark","year":"2002","unstructured":"DE Clark and Grootenhuis P.D.: Progress in computational methods for the prediction of ADMET properties. Curr Opin Drug Discov Dev 2002; 5: 382.","journal-title":"Curr Opin Drug Discov Dev"},{"key":"e_1_3_6_25_2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"van de Waterbeemd H.","year":"2003","unstructured":"van de Waterbeemd H. and Gifford E.: ADMET in silico modelling: towards prediction paradise?. Nat Rev Drug Discov 2003; 2: 192.","journal-title":"Nat Rev Drug Discov"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2004.11.007"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20289"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.10349"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20035"},{"key":"e_1_3_6_31_2","volume-title":"Gaussian 09","author":"Frisch M.J.","year":"2009","unstructured":"Frisch M.J., Trucks G.W., Schlegel H.B. et al: Gaussian 09. Wallingford, CT, USA: Gaussian Inc 2009."},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevA.38.3098"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevB.37.785"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1039\/c0cp00111b"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9991(77)90098-5"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.464397"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008763014207"},{"key":"e_1_3_6_38_2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/hep.32640","article-title":"Macrophage-specific FGF12 promotes liver fibrosis progression in mice","volume":"77","author":"Li S.","year":"2023","unstructured":"Li S., Zhou B., Xue M. et al: Macrophage-specific FGF12 promotes liver fibrosis progression in mice. Hepatology 2023; 77: 816.","journal-title":"Hepatology"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2323236"},{"key":"e_1_3_6_40_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2019.00132","article-title":"Bicuculline reduces neuroinflammation in hippocampus and improves spatial learning and anxiety in hyperammonemic rats. Role of glutamate receptors","volume":"10","author":"Malaguarnera M.","year":"2019","unstructured":"Malaguarnera M., Llansola M., Balzano T. et al: Bicuculline reduces neuroinflammation in hippocampus and improves spatial learning and anxiety in hyperammonemic rats. Role of glutamate receptors. Front Pharm 2019; 10: 132.","journal-title":"Front Pharm"},{"key":"e_1_3_6_41_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0306-4522(87)90194-1","article-title":"Redistribution of transmitter amino acids in rat hippocampus and cerebellum during seizures induced by L-allylglycine and bicuculline: an immunocytochemical study with antisera against conjugated GABA, glutamate and aspartate","volume":"22","author":"Meldrum B.S.","year":"1987","unstructured":"Meldrum B.S., Swan J.H., Ottersen O.P. et al: Redistribution of transmitter amino acids in rat hippocampus and cerebellum during seizures induced by L-allylglycine and bicuculline: an immunocytochemical study with antisera against conjugated GABA, glutamate and aspartate. Neuroscience 1987; 22: 17.","journal-title":"Neuroscience"},{"key":"e_1_3_6_42_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden S.","year":"2015","unstructured":"Genheden S. and Ryde U.: The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Dis 2015; 10: 449.","journal-title":"Expert Opin Drug Dis"},{"key":"e_1_3_6_43_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-beta in progression of liver disease","volume":"347","author":"Dooley S.","year":"2012","unstructured":"Dooley S. and ten Dijke P.: TGF-beta in progression of liver disease. Cell Tissue Res 2012; 347: 245.","journal-title":"Cell Tissue Res"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1663"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.05.007"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i6.755"},{"key":"e_1_3_6_47_2","doi-asserted-by":"crossref","DOI":"10.3389\/jpps.2023.11808","article-title":"Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches","volume":"26","author":"Mohammed O.S.","year":"2023","unstructured":"Mohammed O.S., Attia H.G., Mohamed B. et al: Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches. J Pharm Pharm Sci 2023; 26: 11808.","journal-title":"J Pharm Pharm Sci"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00372-7"},{"key":"e_1_3_6_49_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula","volume":"251","author":"Li H.","year":"2020","unstructured":"Li H.: Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula. J Ethnopharmacol 2020; 251: 112442.","journal-title":"J Ethnopharmacol"},{"key":"e_1_3_6_50_2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fnut.2022.956218","article-title":"Phillyrin restores metabolic disorders in mice fed with high-fat diet through inhibition of interleukin-6-mediated basal lipolysis","volume":"9","author":"Fang Z.","year":"2022","unstructured":"Fang Z., Wei L., Lv Y. et al: Phillyrin restores metabolic disorders in mice fed with high-fat diet through inhibition of interleukin-6-mediated basal lipolysis. Front Nutr 2022; 9: 2022.","journal-title":"Front Nutr"},{"key":"e_1_3_6_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155336"},{"key":"e_1_3_6_52_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini E.G.","year":"2005","unstructured":"Giannini E.G., Testa R. and Savarino V.: Liver enzyme alteration: a guide for clinicians. Can Med Assoc J 2005; 172: 367.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_6_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.38"},{"key":"e_1_3_6_54_2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0002-9440(10)64300-3","article-title":"Identification and characterization of the hepatic stellate cell transferrin receptor","volume":"162","author":"Bridle K.R.","year":"2003","unstructured":"Bridle K.R., Crawford D.H. and Ramm G.A.: Identification and characterization of the hepatic stellate cell transferrin receptor. Am J Pathol 2003; 162: 1661.","journal-title":"Am J Pathol"},{"key":"e_1_3_6_55_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2651"},{"key":"e_1_3_6_56_2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/aps.2015.129","article-title":"Cultured Mycelium Cordyceps sinensis allevi notates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells","volume":"37","author":"Peng Y.","year":"2016","unstructured":"Peng Y., Huang K., Shen L. et al: Cultured Mycelium Cordyceps sinensis allevi notates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells. Acta Pharmacol Sin 2016; 37: 204.","journal-title":"Acta Pharmacol Sin"},{"key":"e_1_3_6_57_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0030-1255353","article-title":"Toll-like receptor 4 and hepatic fibrogenesis","volume":"30","author":"Pradere J.P.","year":"2010","unstructured":"Pradere J.P., Troeger J.S., Dapito D.H. et al: Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis 2010; 30: 232.","journal-title":"Semin Liver Dis"},{"key":"e_1_3_6_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni809"},{"key":"e_1_3_6_59_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bph.12127","article-title":"Advantages of an antagonist: bicuculline and other GABA antagonists","volume":"169","author":"Johnston G.A.","year":"2013","unstructured":"Johnston G.A.: Advantages of an antagonist: bicuculline and other GABA antagonists. Br J Pharm 2013; 169: 328.","journal-title":"Br J Pharm"},{"key":"e_1_3_6_60_2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.csbj.2024.04.016","article-title":"TCMM: a unified database for traditional Chinese medicine modernization and therapeutic innovations","volume":"23","author":"Ren Z.","year":"2024","unstructured":"Ren Z., Ren Y., Li Z. et al: TCMM: a unified database for traditional Chinese medicine modernization and therapeutic innovations. Comput Struct Biotechnol J 2024; 23: 1619.","journal-title":"Comput Struct Biotechnol J"},{"key":"e_1_3_6_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2023.11.030"},{"key":"e_1_3_6_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2024.10.035"},{"key":"e_1_3_6_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02006"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702500563X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S200103702500563X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.12.026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:27:06Z","timestamp":1778012826000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.12.026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["10.1016\/j.csbj.2025.12.026"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.12.026","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bicuculline from Forsythia suspensa attenuates liver fibrosis via TLR4\/MD2 inhibition and suppression of MyD88\/NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}